Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy N Kolishetti, S Dhar, PM Valencia, LQ Lin, R Karnik, SJ Lippard, R Langer, ... Proceedings of the National Academy of Sciences 107 (42), 17939-17944, 2010 | 658 | 2010 |
Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo S Dhar, N Kolishetti, SJ Lippard, OC Farokhzad Proceedings of the National Academy of Sciences 108 (5), 1850-1855, 2011 | 581 | 2011 |
Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt (IV) pro-drug MA Miller, YR Zheng, S Gadde, C Pfirschke, H Zope, C Engblom, ... Nature communications 6 (1), 8692, 2015 | 440 | 2015 |
αVβ3 Integrin-Targeted PLGA-PEG Nanoparticles for Enhanced Anti-tumor Efficacy of a Pt(IV) Prodrug N Graf, DR Bielenberg, N Kolishetti, C Muus, J Banyard, OC Farokhzad, ... ACS nano 6 (5), 4530-4539, 2012 | 343 | 2012 |
Emerging nanotechnology approaches for HIV/AIDS treatment and prevention T Mamo, EA Moseman, N Kolishetti, C Salvador-Morales, J Shi, ... Nanomedicine 5 (2), 269-285, 2010 | 293 | 2010 |
Targeted nanoparticles in mitochondrial medicine RK Pathak, N Kolishetti, S Dhar Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 7 (3 …, 2015 | 143 | 2015 |
Nanoparticles for targeted and temporally controlled drug delivery A Swami, J Shi, S Gadde, AR Votruba, N Kolishetti, OC Farokhzad Multifunctional nanoparticles for drug delivery applications: imaging …, 2012 | 116 | 2012 |
Nanotechnology inspired tools for mitochondrial dysfunction related diseases R Wen, B Banik, RK Pathak, A Kumar, N Kolishetti, S Dhar Advanced drug delivery reviews 99, 52-69, 2016 | 110 | 2016 |
Metabolic modulation of the tumor microenvironment leads to multiple checkpoint inhibition and immune cell infiltration D Kolb, N Kolishetti, B Surnar, S Sarkar, S Guin, AS Shah, S Dhar ACS nano 14 (9), 11055-11066, 2020 | 85 | 2020 |
Nanostructures for drug delivery SJ Lippard, S Dhar, OC Farokhzad, FX Gu, N Kolishetti US Patent 8,906,417, 2014 | 80 | 2014 |
Orally administrable therapeutic synthetic nanoparticle for Zika virus B Surnar, MZ Kamran, AS Shah, U Basu, N Kolishetti, S Deo, ... ACS nano 13 (10), 11034-11048, 2019 | 66 | 2019 |
Particles for multiple agent delivery OC Farokhzad, N Kolishetti, S Dhar, SJ Lippard, RS Langer, PM Valencia US Patent App. 13/515,668, 2013 | 64 | 2013 |
Multifunctionalization of polymers by strain-promoted cycloadditions PA Ledin, N Kolishetti, GJ Boons Macromolecules 46 (19), 7759-7768, 2013 | 61 | 2013 |
A prodrug of two approved drugs, cisplatin and chlorambucil, for chemo war against cancer RK Pathak, R Wen, N Kolishetti, S Dhar Molecular cancer therapeutics 16 (4), 625-636, 2017 | 55 | 2017 |
Cannabidiol for neurodegenerative disorders: A comprehensive review S Bhunia, N Kolishetti, AY Arias, A Vashist, M Nair Frontiers in pharmacology 13, 989717, 2022 | 50 | 2022 |
Evaluation of nanoparticle delivered cisplatin in beagles B Feldhaeusser, SR Platt, S Marrache, N Kolishetti, RK Pathak, ... Nanoscale 7 (33), 13822-13830, 2015 | 44 | 2015 |
Nanocarriers for tracking and treating diseases S Marrache, R Kumar Pathak, K L Darley, J H Choi, D Zaver, N Kolishetti, ... Current medicinal chemistry 20 (28), 3500-3514, 2013 | 44 | 2013 |
An efficient bulk‐heterojunction photovoltaic cell based on energy transfer in graded‐bandgap polymers D Gupta, D Kabra, N Kolishetti, S Ramakrishnan, KS Narayan Advanced Functional Materials 17 (2), 226-232, 2007 | 42 | 2007 |
Development of therapeutic polymeric nanoparticles for the resolution of inflammation S Gadde, O Even‐Or, N Kamaly, A Hasija, PG Gagnon, KH Adusumilli, ... Advanced healthcare materials 3 (9), 1448-1456, 2014 | 39 | 2014 |
Inhibition of Amyloid-Beta production, associated neuroinflammation, and Histone Deacetylase 2-mediated epigenetic modifications prevent neuropathology in Alzheimer’s disease … VSR Atluri, S Tiwari, M Rodriguez, A Kaushik, A Yndart, N Kolishetti, ... Frontiers in Aging Neuroscience 11, 342, 2020 | 38 | 2020 |